GH Research PLCNASDAQ:GHRS
- LAST PRICE11.1900
- TODAY'S CHANGE (%)0.2000 (1.8198%)
- Bid / Lots10.2800/ 1
- Ask / Lots13.5000/ 3
- Open / Previous Close11.1300 / 10.9900
- Day Range
- 52 Week Range
- Volume250,663
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GHRS |
|---|---|---|
| 09:32 ET | 1686 | 11.31 |
| 09:36 ET | 3384 | 10.9 |
| 09:38 ET | 1075 | 10.95 |
| 09:39 ET | 400 | 10.95 |
| 09:41 ET | 100 | 10.92 |
| 09:43 ET | 1000 | 10.97 |
| 09:45 ET | 300 | 10.98 |
| 09:52 ET | 100 | 10.965 |
| 09:59 ET | 16045 | 10.78 |
| 10:01 ET | 8822 | 10.905 |
| 10:06 ET | 1300 | 10.92 |
| 10:08 ET | 590 | 10.915 |
| 10:10 ET | 300 | 10.93 |
| 10:15 ET | 500 | 11 |
| 10:24 ET | 899 | 10.92 |
| 10:53 ET | 200 | 11.01 |
| 11:04 ET | 4468 | 11.08 |
| 11:11 ET | 4719 | 11.16 |
| 11:18 ET | 281 | 11.0545 |
| 11:33 ET | 381 | 10.981 |
| 11:38 ET | 100 | 11.01 |
| 11:40 ET | 2537 | 11 |
| 11:42 ET | 706 | 11 |
| 11:44 ET | 3862 | 11.05 |
| 11:49 ET | 100 | 11.05 |
| 11:51 ET | 200 | 11.03 |
| 12:05 ET | 100 | 11.01 |
| 12:07 ET | 1550 | 11 |
| 12:14 ET | 100 | 11 |
| 12:27 ET | 100 | 11 |
| 12:30 ET | 9881 | 11 |
| 12:32 ET | 15296 | 10.9 |
| 12:34 ET | 12055 | 11.01 |
| 12:50 ET | 6983 | 11 |
| 12:52 ET | 86444 | 11 |
| 12:56 ET | 6898 | 11 |
| 12:59 ET | 2760 | 11.035 |
| 01:03 ET | 300 | 11.07 |
| 01:06 ET | 100 | 11.08 |
| 01:37 ET | 400 | 11.035 |
| 01:39 ET | 100 | 11.01 |
| 01:50 ET | 800 | 11.135 |
| 02:13 ET | 100 | 11.03 |
| 02:33 ET | 100 | 11 |
| 02:36 ET | 4010 | 11 |
| 02:38 ET | 100 | 11 |
| 02:40 ET | 3870 | 11 |
| 02:42 ET | 200 | 11 |
| 02:47 ET | 200 | 11 |
| 02:49 ET | 200 | 11 |
| 02:56 ET | 200 | 11 |
| 02:58 ET | 100 | 11 |
| 03:00 ET | 300 | 11 |
| 03:12 ET | 400 | 11.04 |
| 03:30 ET | 199 | 11 |
| 03:38 ET | 700 | 11.08 |
| 03:48 ET | 100 | 11.01 |
| 03:50 ET | 200 | 11.09 |
| 03:52 ET | 455 | 11.08 |
| 03:54 ET | 100 | 11.11 |
| 03:56 ET | 1132 | 11.18 |
| 03:59 ET | 1800 | 11.19 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
GH Research PLC | 571.8M | -16.4x | --- |
Phathom Pharmaceuticals Inc | 573.5M | -2.4x | --- |
Astria Therapeutics Inc | 579.2M | -4.5x | --- |
Compass Pathways PLC | 583.0M | -3.5x | --- |
Korro Bio Inc | 555.9M | -1.0x | --- |
Prime Medicine Inc | 591.3M | -2.1x | --- |
Company Information
GH Research PLC is a clinical-stage biopharmaceutical company. The Company is engaged in offering treatment for psychiatric and neurological disorders. The Company's pipeline includes GH001, GH002 and GH003. The Company focuses on developing its 5- Methoxy-N, N-Dimethyltryptamine, (5-MeO-DMT), therapies for the treatment of patients with Treatment Resistant Depression (TRD). Its product candidate, GH001, is formulated for 5-MeO-DMT administration via an inhalation approach. With GH001, the Company has completed two Phase 1 healthy volunteer clinical trials and a Phase 1/2 clinical trial in patients with treatment-resistant depression (TRD). The GH002 is a 5-MeO-DMT product candidate formulated for administration via an injectable approach. GH002 has completed pre-clinical development to support early clinical trials. The GH003 is a 5-MeO-DMT product candidate formulated for administration via an intranasal administration approach.
Contact Information
- Headquarters
- Joshua Dawson House, Dawson StreetDublin, Ireland D02 RY95
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Florian Schonharting
- Chief Executive Officer
- Theis Terwey
- Non-Executive Independent Vice Chairman of the Board
- Michael Forer
- Vice President - Finance
- Julie Ryan
- Managing Director, Ireland
- Magnus Halle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $571.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.68 |
Book Value | $4.21 |
P/E Ratio | -16.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
